HA
CELG

Havens Advisors’s Celgene Corp CELG Stock Holding History

Havens Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-146,600
Closed -$14.6M – 44
2019
Q3 		$14.6M Buy
146,600
+16,600
+13% +$1.58M 13.25% 1
2019
Q2 		$12M Buy
130,000
+45,000
+53% +$4.27M 8.45% 3
2019
Q1 		$8.02M Buy
+85,000
New +$7.43M 7.76% 2

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Havens Advisors's CELG Position: Q4 2019 in Review

Havens Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 146,600 shares — an estimated $14.6M sold.

Havens Advisors first reported a position in CELG in Q1 2019 and held it in 3 quarters. The position peaked at $14.6M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Havens Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Havens Advisors sold 146,600 Celgene Corp shares in Q4 2019, an estimated $14.6M.
  • Havens Advisors first reported a position in Celgene Corp in Q1 2019 and held it in 3 quarters.
  • Havens Advisors's Celgene Corp position peaked at $14.6M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Havens Advisors's 13F filing for Q4 2019, filed 27 Jan 2020.